Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia

Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia

IntroductionInduction intravesical Bacillus Calmette-Guerin (BCG) followed by maintenance after transurethral resection of bladder tumor, is the standard adjuvant therapy for high-risk non-muscle invasive bladder cancer (NMIBC). There is sparse evidence on the practice of intravesical BCG in Austral...

Full description

Bibliographic Details
Main Authors: Chamodi Pillippu Hewa, Stephen Della-Fiorentina, Kayvan Haghighi, Wei Chua, Peey-Sei Kok
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Urology
Subjects:
intravesical BCG
NMIBC
disease-free survival
bladder cancer
TURBT
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fruro.2024.1309532/full

Internet

https://www.frontiersin.org/articles/10.3389/fruro.2024.1309532/full

Similar Items